Kidney Cancer Trial, Recruiting (NCT04987086)

Kidney Cancer Trial, Recruiting NCT04987086 Sponsor: Xijing Hospital Condition: Kidney Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04987086 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Kidney Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with kidney cancer that has been classified as Stage III or Stage IV (meaning it has spread locally or to other parts of the body)
A CT scan with contrast dye has found areas that may be signs of cancer spread (suspected metastases)
You have no known problems with your veins (either in your arms/legs or deeper in your body)
You are able to have a special type of scan called a 68Ga PSMA PET/CT within 6 weeks of your kidney cancer diagnosis
You are willing to participate and have signed a consent form agreeing to take part in the trial

Who may not be able to join:

You are 18 years old or younger
You are unable to lie flat during the PET/CT scan
You have a medical reason why you cannot receive the 68Ga PSMA substance used in the scan (confirm with trial site)
You have been diagnosed with another type of cancer in the past two years, or your doctor believes other health complications could interfere with the trial
Your kidneys are not working properly, or you are currently receiving kidney dialysis treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04987086

Sponsor: Xijing Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Kidney Cancer

More information: https://clinicaltrials.gov/study/NCT04987086

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with kidney cancer that has been classified as Stage III or Stage IV (meaning it has spread locally or to other parts of the body)
A CT scan with contrast dye has found areas that may be signs of cancer spread (suspected metastases)
You have no known problems with your veins (either in your arms/legs or deeper in your body)
You are able to have a special type of scan called a 68Ga PSMA PET/CT within 6 weeks of your kidney cancer diagnosis
You are willing to participate and have signed a consent form agreeing to take part in the trial

Who may not be able to join:

You are 18 years old or younger
You are unable to lie flat during the PET/CT scan
You have a medical reason why you cannot receive the 68Ga PSMA substance used in the scan (confirm with trial site)
You have been diagnosed with another type of cancer in the past two years, or your doctor believes other health complications could interfere with the trial
Your kidneys are not working properly, or you are currently receiving kidney dialysis treatment

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Xijing Hospital

Registry

ClinicalTrials.gov

Start date

1 June 2021

Est. completion

1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Additional diagnostic value of 68Ga PSMA PET / CT compared with CT in patients with locally advanced and advanced renal cell carcinoma

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov